Neurodegenerative Diseases Therapeutics Market, Global Outlook and Forecast 2023-2028

Report ID: 1785484 | Published Date: Jan 2025 | No. of Page: 61 | Base Year: 2024 | Rating: 4.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Introduction to Research & Analysis Reports
    1.1 Neurodegenerative Diseases Therapeutics Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Neurodegenerative Diseases Therapeutics Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Neurodegenerative Diseases Therapeutics Overall Market Size
    2.1 Global Neurodegenerative Diseases Therapeutics Market Size: 2021 VS 2028
    2.2 Global Neurodegenerative Diseases Therapeutics Market Size, Prospects & Forecasts: 2017-2028
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Neurodegenerative Diseases Therapeutics Players in Global Market
    3.2 Top Global Neurodegenerative Diseases Therapeutics Companies Ranked by Revenue
    3.3 Global Neurodegenerative Diseases Therapeutics Revenue by Companies
    3.4 Top 3 and Top 5 Neurodegenerative Diseases Therapeutics Companies in Global Market, by Revenue in 2021
    3.5 Global Companies Neurodegenerative Diseases Therapeutics Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Neurodegenerative Diseases Therapeutics Players in Global Market
        3.6.1 List of Global Tier 1 Neurodegenerative Diseases Therapeutics Companies
        3.6.2 List of Global Tier 2 and Tier 3 Neurodegenerative Diseases Therapeutics Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 by Type - Global Neurodegenerative Diseases Therapeutics Market Size Markets, 2021 & 2028
        4.1.2 Multiple Sclerosis Therapeutics
        4.1.3 Alzheimer's Disease Therapeutics
        4.1.4 Parkinson's Disease Therapeutics
        4.1.5 Parkinson's Disease Therapeutics
        4.1.6 Others
    4.2 By Type - Global Neurodegenerative Diseases Therapeutics Revenue & Forecasts
        4.2.1 By Type - Global Neurodegenerative Diseases Therapeutics Revenue, 2017-2022
        4.2.2 By Type - Global Neurodegenerative Diseases Therapeutics Revenue, 2023-2028
        4.2.3 By Type - Global Neurodegenerative Diseases Therapeutics Revenue Market Share, 2017-2028
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Neurodegenerative Diseases Therapeutics Market Size, 2021 & 2028
        5.1.2 Child
        5.1.3 Aldult
    5.2 By Application - Global Neurodegenerative Diseases Therapeutics Revenue & Forecasts
        5.2.1 By Application - Global Neurodegenerative Diseases Therapeutics Revenue, 2017-2022
        5.2.2 By Application - Global Neurodegenerative Diseases Therapeutics Revenue, 2023-2028
        5.2.3 By Application - Global Neurodegenerative Diseases Therapeutics Revenue Market Share, 2017-2028
6 Sights by Region
    6.1 By Region - Global Neurodegenerative Diseases Therapeutics Market Size, 2021 & 2028
    6.2 By Region - Global Neurodegenerative Diseases Therapeutics Revenue & Forecasts
        6.2.1 By Region - Global Neurodegenerative Diseases Therapeutics Revenue, 2017-2022
        6.2.2 By Region - Global Neurodegenerative Diseases Therapeutics Revenue, 2023-2028
        6.2.3 By Region - Global Neurodegenerative Diseases Therapeutics Revenue Market Share, 2017-2028
    6.3 North America
        6.3.1 By Country - North America Neurodegenerative Diseases Therapeutics Revenue, 2017-2028
        6.3.2 US Neurodegenerative Diseases Therapeutics Market Size, 2017-2028
        6.3.3 Canada Neurodegenerative Diseases Therapeutics Market Size, 2017-2028
        6.3.4 Mexico Neurodegenerative Diseases Therapeutics Market Size, 2017-2028
    6.4 Europe
        6.4.1 By Country - Europe Neurodegenerative Diseases Therapeutics Revenue, 2017-2028
        6.4.2 Germany Neurodegenerative Diseases Therapeutics Market Size, 2017-2028
        6.4.3 France Neurodegenerative Diseases Therapeutics Market Size, 2017-2028
        6.4.4 U.K. Neurodegenerative Diseases Therapeutics Market Size, 2017-2028
        6.4.5 Italy Neurodegenerative Diseases Therapeutics Market Size, 2017-2028
        6.4.6 Russia Neurodegenerative Diseases Therapeutics Market Size, 2017-2028
        6.4.7 Nordic Countries Neurodegenerative Diseases Therapeutics Market Size, 2017-2028
        6.4.8 Benelux Neurodegenerative Diseases Therapeutics Market Size, 2017-2028
    6.5 Asia
        6.5.1 By Region - Asia Neurodegenerative Diseases Therapeutics Revenue, 2017-2028
        6.5.2 China Neurodegenerative Diseases Therapeutics Market Size, 2017-2028
        6.5.3 Japan Neurodegenerative Diseases Therapeutics Market Size, 2017-2028
        6.5.4 South Korea Neurodegenerative Diseases Therapeutics Market Size, 2017-2028
        6.5.5 Southeast Asia Neurodegenerative Diseases Therapeutics Market Size, 2017-2028
        6.5.6 India Neurodegenerative Diseases Therapeutics Market Size, 2017-2028
    6.6 South America
        6.6.1 By Country - South America Neurodegenerative Diseases Therapeutics Revenue, 2017-2028
        6.6.2 Brazil Neurodegenerative Diseases Therapeutics Market Size, 2017-2028
        6.6.3 Argentina Neurodegenerative Diseases Therapeutics Market Size, 2017-2028
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Neurodegenerative Diseases Therapeutics Revenue, 2017-2028
        6.7.2 Turkey Neurodegenerative Diseases Therapeutics Market Size, 2017-2028
        6.7.3 Israel Neurodegenerative Diseases Therapeutics Market Size, 2017-2028
        6.7.4 Saudi Arabia Neurodegenerative Diseases Therapeutics Market Size, 2017-2028
        6.7.5 UAE Neurodegenerative Diseases Therapeutics Market Size, 2017-2028
7 Players Profiles
    7.1 AB Science SA
        7.1.1 AB Science SA Corporate Summary
        7.1.2 AB Science SA Business Overview
        7.1.3 AB Science SA Neurodegenerative Diseases Therapeutics Major Product Offerings
        7.1.4 AB Science SA Neurodegenerative Diseases Therapeutics Revenue in Global Market (2017-2022)
        7.1.5 AB Science SA Key News
    7.2 AbbVie Inc.
        7.2.1 AbbVie Inc. Corporate Summary
        7.2.2 AbbVie Inc. Business Overview
        7.2.3 AbbVie Inc. Neurodegenerative Diseases Therapeutics Major Product Offerings
        7.2.4 AbbVie Inc. Neurodegenerative Diseases Therapeutics Revenue in Global Market (2017-2022)
        7.2.5 AbbVie Inc. Key News
    7.3 Acadia Pharmaceuticals Inc.
        7.3.1 Acadia Pharmaceuticals Inc. Corporate Summary
        7.3.2 Acadia Pharmaceuticals Inc. Business Overview
        7.3.3 Acadia Pharmaceuticals Inc. Neurodegenerative Diseases Therapeutics Major Product Offerings
        7.3.4 Acadia Pharmaceuticals Inc. Neurodegenerative Diseases Therapeutics Revenue in Global Market (2017-2022)
        7.3.5 Acadia Pharmaceuticals Inc. Key News
    7.4 Biogen Inc.
        7.4.1 Biogen Inc. Corporate Summary
        7.4.2 Biogen Inc. Business Overview
        7.4.3 Biogen Inc. Neurodegenerative Diseases Therapeutics Major Product Offerings
        7.4.4 Biogen Inc. Neurodegenerative Diseases Therapeutics Revenue in Global Market (2017-2022)
        7.4.5 Biogen Inc. Key News
    7.5 F. Hoffmann La Roche Ltd.
        7.5.1 F. Hoffmann La Roche Ltd. Corporate Summary
        7.5.2 F. Hoffmann La Roche Ltd. Business Overview
        7.5.3 F. Hoffmann La Roche Ltd. Neurodegenerative Diseases Therapeutics Major Product Offerings
        7.5.4 F. Hoffmann La Roche Ltd. Neurodegenerative Diseases Therapeutics Revenue in Global Market (2017-2022)
        7.5.5 F. Hoffmann La Roche Ltd. Key News
    7.6 H Lundbeck AS
        7.6.1 H Lundbeck AS Corporate Summary
        7.6.2 H Lundbeck AS Business Overview
        7.6.3 H Lundbeck AS Neurodegenerative Diseases Therapeutics Major Product Offerings
        7.6.4 H Lundbeck AS Neurodegenerative Diseases Therapeutics Revenue in Global Market (2017-2022)
        7.6.5 H Lundbeck AS Key News
    7.7 Mitsubishi Chemical Holdings Corp.
        7.7.1 Mitsubishi Chemical Holdings Corp. Corporate Summary
        7.7.2 Mitsubishi Chemical Holdings Corp. Business Overview
        7.7.3 Mitsubishi Chemical Holdings Corp. Neurodegenerative Diseases Therapeutics Major Product Offerings
        7.7.4 Mitsubishi Chemical Holdings Corp. Neurodegenerative Diseases Therapeutics Revenue in Global Market (2017-2022)
        7.7.5 Mitsubishi Chemical Holdings Corp. Key News
    7.8 Novartis AG
        7.8.1 Novartis AG Corporate Summary
        7.8.2 Novartis AG Business Overview
        7.8.3 Novartis AG Neurodegenerative Diseases Therapeutics Major Product Offerings
        7.8.4 Novartis AG Neurodegenerative Diseases Therapeutics Revenue in Global Market (2017-2022)
        7.8.5 Novartis AG Key News
    7.9 Sanofi
        7.9.1 Sanofi Corporate Summary
        7.9.2 Sanofi Business Overview
        7.9.3 Sanofi Neurodegenerative Diseases Therapeutics Major Product Offerings
        7.9.4 Sanofi Neurodegenerative Diseases Therapeutics Revenue in Global Market (2017-2022)
        7.9.5 Sanofi Key News
    7.10 Teva Pharmaceutical Industries Ltd
        7.10.1 Teva Pharmaceutical Industries Ltd Corporate Summary
        7.10.2 Teva Pharmaceutical Industries Ltd Business Overview
        7.10.3 Teva Pharmaceutical Industries Ltd Neurodegenerative Diseases Therapeutics Major Product Offerings
        7.10.4 Teva Pharmaceutical Industries Ltd Neurodegenerative Diseases Therapeutics Revenue in Global Market (2017-2022)
        7.10.5 Teva Pharmaceutical Industries Ltd Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

List of Tables
    Table 1. Neurodegenerative Diseases Therapeutics Market Opportunities & Trends in Global Market
    Table 2. Neurodegenerative Diseases Therapeutics Market Drivers in Global Market
    Table 3. Neurodegenerative Diseases Therapeutics Market Restraints in Global Market
    Table 4. Key Players of Neurodegenerative Diseases Therapeutics in Global Market
    Table 5. Top Neurodegenerative Diseases Therapeutics Players in Global Market, Ranking by Revenue (2021)
    Table 6. Global Neurodegenerative Diseases Therapeutics Revenue by Companies, (US$, Mn), 2017-2022
    Table 7. Global Neurodegenerative Diseases Therapeutics Revenue Share by Companies, 2017-2022
    Table 8. Global Companies Neurodegenerative Diseases Therapeutics Product Type
    Table 9. List of Global Tier 1 Neurodegenerative Diseases Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Neurodegenerative Diseases Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Neurodegenerative Diseases Therapeutics Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Neurodegenerative Diseases Therapeutics Revenue in Global (US$, Mn), 2017-2022
    Table 13. By Type - Neurodegenerative Diseases Therapeutics Revenue in Global (US$, Mn), 2023-2028
    Table 14. By Application – Global Neurodegenerative Diseases Therapeutics Revenue, (US$, Mn), 2021 & 2028
    Table 15. By Application - Neurodegenerative Diseases Therapeutics Revenue in Global (US$, Mn), 2017-2022
    Table 16. By Application - Neurodegenerative Diseases Therapeutics Revenue in Global (US$, Mn), 2023-2028
    Table 17. By Region – Global Neurodegenerative Diseases Therapeutics Revenue, (US$, Mn), 2021 & 2028
    Table 18. By Region - Global Neurodegenerative Diseases Therapeutics Revenue (US$, Mn), 2017-2022
    Table 19. By Region - Global Neurodegenerative Diseases Therapeutics Revenue (US$, Mn), 2023-2028
    Table 20. By Country - North America Neurodegenerative Diseases Therapeutics Revenue, (US$, Mn), 2017-2022
    Table 21. By Country - North America Neurodegenerative Diseases Therapeutics Revenue, (US$, Mn), 2023-2028
    Table 22. By Country - Europe Neurodegenerative Diseases Therapeutics Revenue, (US$, Mn), 2017-2022
    Table 23. By Country - Europe Neurodegenerative Diseases Therapeutics Revenue, (US$, Mn), 2023-2028
    Table 24. By Region - Asia Neurodegenerative Diseases Therapeutics Revenue, (US$, Mn), 2017-2022
    Table 25. By Region - Asia Neurodegenerative Diseases Therapeutics Revenue, (US$, Mn), 2023-2028
    Table 26. By Country - South America Neurodegenerative Diseases Therapeutics Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - South America Neurodegenerative Diseases Therapeutics Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - Middle East & Africa Neurodegenerative Diseases Therapeutics Revenue, (US$, Mn), 2017-2022
    Table 29. By Country - Middle East & Africa Neurodegenerative Diseases Therapeutics Revenue, (US$, Mn), 2023-2028
    Table 30. AB Science SA Corporate Summary
    Table 31. AB Science SA Neurodegenerative Diseases Therapeutics Product Offerings
    Table 32. AB Science SA Neurodegenerative Diseases Therapeutics Revenue (US$, Mn), (2017-2022)
    Table 33. AbbVie Inc. Corporate Summary
    Table 34. AbbVie Inc. Neurodegenerative Diseases Therapeutics Product Offerings
    Table 35. AbbVie Inc. Neurodegenerative Diseases Therapeutics Revenue (US$, Mn), (2017-2022)
    Table 36. Acadia Pharmaceuticals Inc. Corporate Summary
    Table 37. Acadia Pharmaceuticals Inc. Neurodegenerative Diseases Therapeutics Product Offerings
    Table 38. Acadia Pharmaceuticals Inc. Neurodegenerative Diseases Therapeutics Revenue (US$, Mn), (2017-2022)
    Table 39. Biogen Inc. Corporate Summary
    Table 40. Biogen Inc. Neurodegenerative Diseases Therapeutics Product Offerings
    Table 41. Biogen Inc. Neurodegenerative Diseases Therapeutics Revenue (US$, Mn), (2017-2022)
    Table 42. F. Hoffmann La Roche Ltd. Corporate Summary
    Table 43. F. Hoffmann La Roche Ltd. Neurodegenerative Diseases Therapeutics Product Offerings
    Table 44. F. Hoffmann La Roche Ltd. Neurodegenerative Diseases Therapeutics Revenue (US$, Mn), (2017-2022)
    Table 45. H Lundbeck AS Corporate Summary
    Table 46. H Lundbeck AS Neurodegenerative Diseases Therapeutics Product Offerings
    Table 47. H Lundbeck AS Neurodegenerative Diseases Therapeutics Revenue (US$, Mn), (2017-2022)
    Table 48. Mitsubishi Chemical Holdings Corp. Corporate Summary
    Table 49. Mitsubishi Chemical Holdings Corp. Neurodegenerative Diseases Therapeutics Product Offerings
    Table 50. Mitsubishi Chemical Holdings Corp. Neurodegenerative Diseases Therapeutics Revenue (US$, Mn), (2017-2022)
    Table 51. Novartis AG Corporate Summary
    Table 52. Novartis AG Neurodegenerative Diseases Therapeutics Product Offerings
    Table 53. Novartis AG Neurodegenerative Diseases Therapeutics Revenue (US$, Mn), (2017-2022)
    Table 54. Sanofi Corporate Summary
    Table 55. Sanofi Neurodegenerative Diseases Therapeutics Product Offerings
    Table 56. Sanofi Neurodegenerative Diseases Therapeutics Revenue (US$, Mn), (2017-2022)
    Table 57. Teva Pharmaceutical Industries Ltd Corporate Summary
    Table 58. Teva Pharmaceutical Industries Ltd Neurodegenerative Diseases Therapeutics Product Offerings
    Table 59. Teva Pharmaceutical Industries Ltd Neurodegenerative Diseases Therapeutics Revenue (US$, Mn), (2017-2022)
List of Figures
    Figure 1. Neurodegenerative Diseases Therapeutics Segment by Type in 2021
    Figure 2. Neurodegenerative Diseases Therapeutics Segment by Application in 2021
    Figure 3. Global Neurodegenerative Diseases Therapeutics Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Neurodegenerative Diseases Therapeutics Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Neurodegenerative Diseases Therapeutics Revenue, 2017-2028 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by Neurodegenerative Diseases Therapeutics Revenue in 2021
    Figure 8. By Type - Global Neurodegenerative Diseases Therapeutics Revenue Market Share, 2017-2028
    Figure 9. By Application - Global Neurodegenerative Diseases Therapeutics Revenue Market Share, 2017-2028
    Figure 10. By Region - Global Neurodegenerative Diseases Therapeutics Revenue Market Share, 2017-2028
    Figure 11. By Country - North America Neurodegenerative Diseases Therapeutics Revenue Market Share, 2017-2028
    Figure 12. US Neurodegenerative Diseases Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 13. Canada Neurodegenerative Diseases Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 14. Mexico Neurodegenerative Diseases Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 15. By Country - Europe Neurodegenerative Diseases Therapeutics Revenue Market Share, 2017-2028
    Figure 16. Germany Neurodegenerative Diseases Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 17. France Neurodegenerative Diseases Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 18. U.K. Neurodegenerative Diseases Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 19. Italy Neurodegenerative Diseases Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 20. Russia Neurodegenerative Diseases Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 21. Nordic Countries Neurodegenerative Diseases Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 22. Benelux Neurodegenerative Diseases Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 23. By Region - Asia Neurodegenerative Diseases Therapeutics Revenue Market Share, 2017-2028
    Figure 24. China Neurodegenerative Diseases Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 25. Japan Neurodegenerative Diseases Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 26. South Korea Neurodegenerative Diseases Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 27. Southeast Asia Neurodegenerative Diseases Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 28. India Neurodegenerative Diseases Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 29. By Country - South America Neurodegenerative Diseases Therapeutics Revenue Market Share, 2017-2028
    Figure 30. Brazil Neurodegenerative Diseases Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 31. Argentina Neurodegenerative Diseases Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 32. By Country - Middle East & Africa Neurodegenerative Diseases Therapeutics Revenue Market Share, 2017-2028
    Figure 33. Turkey Neurodegenerative Diseases Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 34. Israel Neurodegenerative Diseases Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 35. Saudi Arabia Neurodegenerative Diseases Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 36. UAE Neurodegenerative Diseases Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 37. AB Science SA Neurodegenerative Diseases Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 38. AbbVie Inc. Neurodegenerative Diseases Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 39. Acadia Pharmaceuticals Inc. Neurodegenerative Diseases Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 40. Biogen Inc. Neurodegenerative Diseases Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 41. F. Hoffmann La Roche Ltd. Neurodegenerative Diseases Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 42. H Lundbeck AS Neurodegenerative Diseases Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 43. Mitsubishi Chemical Holdings Corp. Neurodegenerative Diseases Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 44. Novartis AG Neurodegenerative Diseases Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 45. Sanofi Neurodegenerative Diseases Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 46. Teva Pharmaceutical Industries Ltd Neurodegenerative Diseases Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
Neurodegenerative Diseases Therapeutics Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Neurodegenerative Diseases Therapeutics Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Neurodegenerative Diseases Therapeutics Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports